Genomic epidemiology of Neisseria gonorrhoeae with reduced susceptibility to cefixime in the USA: A retrospective observational study

The Lancet Infectious Diseases

Volumn 14, Issue 3, 2014, Pages 220-226

  Grad, Yonatan H ^a,b   Kirkcaldy, Robert D ^c   Trees, David ^c   Dordel, Janina ^d   Harris, Simon R ^d   Goldstein, Edward ^a   Weinstock, Hillard ^c   Parkhill, Julian ^d   Hanage, William P ^a   Bentley, Stephen ^d,e   Lipsitch, Marc ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI-BACTERIAL AGENTS; CEFIXIME; CEPHALOSPORIN RESISTANCE; GENOME, BACTERIAL; GENOTYPE; GONORRHEA; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MOLECULAR EPIDEMIOLOGY; NEISSERIA GONORRHOEAE; RETROSPECTIVE STUDIES; UNITED STATES; YOUNG ADULT;

AZITHROMYCIN; CEFIXIME; CEPHALOSPORIN; CIPROFLOXACIN; RNA 23S;

ALLELE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENOME; BACTERIUM ISOLATE; DNA SEQUENCE; GENE LOCUS; GENE MUTATION; GENE PRODUCT; GENETIC DISTANCE; GENETIC EPIDEMIOLOGY; GENOME ANALYSIS; GENOTYPE; GEOGRAPHY; GONOCOCCAL URETHRITIS; HETEROSEXUALITY; HOMOLOGOUS RECOMBINATION; HUMAN; HUMAN TISSUE; MALE; MEN WHO HAVE SEX WITH MEN; MINIMUM INHIBITORY CONCENTRATION; MOSAICISM; MULTILOCUS SEQUENCE TYPING; NEISSERIA GONORRHOEAE; NONHUMAN; NUCLEOTIDE SEQUENCE; OBSERVATIONAL STUDY; PHENOTYPE; PHYLOGENETIC TREE; PHYLOGENY; PREDICTIVE VALUE; RETROSPECTIVE STUDY; SEXUAL HEALTH; SEXUAL ORIENTATION; SEXUALITY; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED STATES; WOMEN WHO HAVE SEX WITH WOMEN;

EID: 84894308219     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(13)70693-5     Document Type: Article

References (38)

1. Global incidence and prevalence of selected curable sexually transmitted infections 2008, WHO, World Health Organization, Geneva, (accessed Feb 8, 2013). http://www.who.int/reproductivehealth/publications/rtis/2008_STI_estimates.pdf.
2. Satterwhite CL, Torrone E, Meites E, et al. Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008. Sex Transm Infect 2013, 40:187-193.
3. Kirkcaldy RD, Ballard RC, Dowell D Gonococcal resistance: are cephalosporins next?. Curr Infect Dis Rep 2011, 13:196-204.
4. Bolan GA, Sparling PF, Wasserheit JN The emerging threat of untreatable gonococcal infection. N Engl J Med 2012, 366:485-487.
5. Ison CA, Deal C, Unemo M Current and future treatment options for gonorrhoea. Sex Transm Infect 2013, 89(suppl 4):iv52-iv56.
6. Cephalosporin susceptibility among Neisseria gonorrhoeae isolates-United States, 2000-2010. MMWR Morb Mortal Wkly Rep 2011, 60:873-877.
7. Allen VG, Mitterni L, Seah C, et al. Neisseria gonorrhoeae treatment failure and susceptibility to cefixime in Toronto, Canada. JAMA 2013, 309:163-170.
8. Update to CDC's Sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections. MMWR Morb Mortal Wkly Rep 2012, 61:590-594.
9. Diep BA Use of whole-genome sequencing for outbreak investigations. Lancet Infect Dis 2013, 13:99-101.
10. Gardy JL Investigation of disease outbreaks with genome sequencing. Lancet Infect Dis 2013, 13:101-102.
11. McCarthy N An epidemiological view of microbial genomic data. Lancet Infect Dis 2013, 13:104-105.
12. Increases in fluoroquinolone-resistant Neisseria gonorrhoeae-Hawaii and California, 2001. MMWR Morb Mortal Wkly Rep 2002, 51:1041-1044.
13. Kirkcaldy RD, Zaidi A, Hook EW, et al. Neisseria gonorrhoeae antimicrobial resistance among men who have sex with men and men who have sex exclusively with women: the Gonococcal Isolate Surveillance Project, 2005-2010. Ann Intern Med 2013, 158:321-328.
14. Perine PL, Morton RS, Piot P, Siegel MS, Antal GM Epidemiology and treatment of penicillinase-producing Neisseria gonorrhoeae. Sex Transm Infect 1979, 6(2 suppl):152-158.
15. Gonococcal Isolate Surveillance Project (GISP) protocol CDC, (accessed Dec 31, 2013). http://www.cdc.gov/std/gisp/GISP-Protocol07-15-2010.pdf.
16. Chen CC, Hsia KC, Huang CT, et al. Draft genome sequence of a dominant, multidrug-resistant Neisseria gonorrhoeae strain, TCDC-NG08107, from a sexual group at high risk of acquiring human immunodeficiency virus infection and syphilis. J Bacteriol 2011, 193:1788-1789.
17. Harris SR, Feil EJ, Holden MT, et al. Evolution of MRSA during hospital transmission and intercontinental spread. Science 2010, 327:469-474.
18. Zerbino DR, Birney E Velvet: algorithms for de novo short read assembly using de Bruijn graphs. Genome Res 2008, 18:821-829.
19. Gouy M, Guindon S, Gascuel O SeaView version 4: a multiplatform graphical user interface for sequence alignment and phylogenetic tree building. Mol Biol Evol 2010, 27:221-224.
20. Edgar RC MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res 2004, 32:1792-1797.
21. Guindon S, Gascuel O A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst Biol 2003, 52:696-704.
22. Croucher NJ, Harris SR, Fraser C, et al. Rapid pneumococcal evolution in response to clinical interventions. Science 2011, 331:430-444.
23. Stamatakis A RAxML-VI-HPC: maximum likelihood-based phylogenetic analyses with thousands of taxa and mixed models. Bioinformatics 2006, 22:2688-2690.
24. Drummond AJ, Rambaut A BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol Biol 2007, 7:214.
25. Lemey P, Rambaut A, Drummond AJ, Suchard MA Bayesian phylogeography finds its roots. PLoS Comput Biol 2009, 5:e1000520.
26. Feil EJ, Holmes EC, Bessen DE, et al. Recombination within natural populations of pathogenic bacteria: short-term empirical estimates and long-term phylogenetic consequences. Proc Natl Acad Sci USA 2001, 98:182-187.
27. Muratani T, Akasaka S, Kobayashi T, et al. Outbreak of cefozopran (penicillin, oral cephems, and aztreonam)-resistant Neisseria gonorrhoeae in Japan. Antimicrob Agents Chemother 2001, 45:3603-3606.
28. Ameyama S, Onodera S, Takahata M, et al. Mosaic-like structure of penicillin-binding protein 2 gene (penA) in clinical isolates of Neisseria gonorrhoeae with reduced susceptibility to cefixime. Antimicrob Agents Chemother 2002, 46:3744-3749.
29. Goldstein E, Kirkcaldy RD, Reshef D, et al. Factors related to increasing prevalence of resistance to ciprofloxacin and other antimicrobial drugs in Neisseria gonorrhoeae, United States. Emerg Infect Dis 2012, 18:1290-1297.
30. Ito M, Deguchi T, Mizutani KS, et al. Emergence and spread of Neisseria gonorrhoeae clinical isolates harboring mosaic-like structure of penicillin-binding protein 2 in central Japan. Antimicrob Agents Chemother 2005, 49:137-143.
31. Lee SG, Lee H, Jeong SH, et al. Various penA mutations together with mtrR, porB and ponA mutations in Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime or ceftriaxone. J Antimicrob Chemother 2010, 65:669-675.
32. Veal WL, Nicholas RA, Shafer WM Overexpression of the MtrC-MtrD-MtrE efflux pump due to an mtrR mutation is required for chromosomally mediated penicillin resistance in Neisseria gonorrhoeae. J Bacteriol 2002, 184:5619-5624.
33. Pandori M, Barry PM, Wu A, et al. Mosaic penicillin-binding protein 2 in Neisseria gonorrhoeae isolates collected in 2008 in San Francisco, California. Antimicrob Agents Chemother 2009, 53:4032-4034.
34. Buono S, Wu A, Hess DC, et al. Using the Neisseria gonorrhoeae multiantigen sequence-typing method to assess strain diversity and antibiotic resistance in San Francisco, California. Microb Drug Resist 2012, 18:510-517.
35. Ng LK, Martin I, Liu G, Bryden L Mutation in 23S rRNA associated with macrolide resistance in Neisseria gonorrhoeae. Antimicrob Agents Chemother 2002, 46:3020-3025.
36. Chung GT, Yoo JS, Oh HB, et al. Complete genome sequence of Neisseria gonorrhoeae NCCP11945. J Bacteriol 2008, 190:6035-6036.
37. Hess D, Wu A, Golparian D, et al. Genome sequencing of a Neisseria gonorrhoeae isolate of a successful international clone with decreased susceptibility and resistance to extended-spectrum cephalosporins. Antimicrob Agents Chemother 2012, 56:5633-5641.
38. Ohnishi M, Watanabe Y, Ono E, et al. Spread of a chromosomal cefixime-resistant penA gene among different Neisseria gonorrhoeae lineages. Antimicrob Agents Chemother 2010, 54:1060-1067.